Monoclonal antibodies are lab-made proteins that act like natural antibodies in fighting disease. Derived from human immune cells, these proteins act specifically against targets ranging from cancerous cells to viruses and bacteria, or alter precise immune pathways to augment a…
We will be discussing an experimental therapy for COVID-19 that President Trump was treated with upon arrival at Walter Reed Hospital yesterday where he was admitted for COVID-19. Regeneron created two monoclonal antibodies, one from humans and one from mice,…
What the potential of monoclonal antibodies may be, and what’s currently understood about serologic antibodies.
Link to the full course: In this video, we will deep dive into: 1. Monoclonal antibodies that are under trials for fighting SARS-CoV-2 2. How can monoclonal antibodies be isolated from COVID-19 recovered patients? 3. Generation of fully human monoclonal…
Monoclonal antibodies are man-made to act like human antibodies of the immune system. Dr. Seheult of illustrates how monoclonal antibodies have significant potential for COVID-19 treatment and prevention, and how the results of a recent study show promising results. Dr.…
Celltrion announced positive preliminary results from Phase 1 clinical trial.
